View in EDS

Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains.

Saved in:
Bibliographic Details
Title: Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains.
Authors: Wiener JJ; Johnson & Johnson Pharmaceutical Research & Development L.L.C., 3210 Merryfield Row, San Diego, CA 92121, USA. Jwiener@prdus.jnj.com, Gomez L, Venkatesan H, Santillán A Jr, Allison BD, Schwarz KL, Shinde S, Tang L, Hack MD, Morrow BJ, Motley ST, Goldschmidt RM, Shaw KJ, Jones TK, Grice CA
Source: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2007 May 15; Vol. 17 (10), pp. 2718-22. Date of Electronic Publication: 2007 Mar 06.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0960-894X (Print) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 17382544
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wiener+JJ%22">Wiener JJ</searchLink>; Johnson & Johnson Pharmaceutical Research & Development L.L.C., 3210 Merryfield Row, San Diego, CA 92121, USA. Jwiener@prdus.jnj.com<br /><searchLink fieldCode="AU" term="%22Gomez+L%22">Gomez L</searchLink><br /><searchLink fieldCode="AU" term="%22Venkatesan+H%22">Venkatesan H</searchLink><br /><searchLink fieldCode="AU" term="%22Santillán+A+Jr%22">Santillán A Jr</searchLink><br /><searchLink fieldCode="AU" term="%22Allison+BD%22">Allison BD</searchLink><br /><searchLink fieldCode="AU" term="%22Schwarz+KL%22">Schwarz KL</searchLink><br /><searchLink fieldCode="AU" term="%22Shinde+S%22">Shinde S</searchLink><br /><searchLink fieldCode="AU" term="%22Tang+L%22">Tang L</searchLink><br /><searchLink fieldCode="AU" term="%22Hack+MD%22">Hack MD</searchLink><br /><searchLink fieldCode="AU" term="%22Morrow+BJ%22">Morrow BJ</searchLink><br /><searchLink fieldCode="AU" term="%22Motley+ST%22">Motley ST</searchLink><br /><searchLink fieldCode="AU" term="%22Goldschmidt+RM%22">Goldschmidt RM</searchLink><br /><searchLink fieldCode="AU" term="%22Shaw+KJ%22">Shaw KJ</searchLink><br /><searchLink fieldCode="AU" term="%22Jones+TK%22">Jones TK</searchLink><br /><searchLink fieldCode="AU" term="%22Grice+CA%22">Grice CA</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229107377%22">Bioorganic & medicinal chemistry letters</searchLink> [Bioorg Med Chem Lett] 2007 May 15; Vol. 17 (10), pp. 2718-22. <i>Date of Electronic Publication: </i>2007 Mar 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9107377 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>0960-894X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220960894X%22">0960894X </searchLink><i>NLM ISO Abbreviation: </i>Bioorg Med Chem Lett <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=17382544
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.bmcl.2007.03.004
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2718
    Titles:
      – TitleFull: Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wiener JJ
      – PersonEntity:
          Name:
            NameFull: Gomez L
      – PersonEntity:
          Name:
            NameFull: Venkatesan H
      – PersonEntity:
          Name:
            NameFull: Santillán A Jr
      – PersonEntity:
          Name:
            NameFull: Allison BD
      – PersonEntity:
          Name:
            NameFull: Schwarz KL
      – PersonEntity:
          Name:
            NameFull: Shinde S
      – PersonEntity:
          Name:
            NameFull: Tang L
      – PersonEntity:
          Name:
            NameFull: Hack MD
      – PersonEntity:
          Name:
            NameFull: Morrow BJ
      – PersonEntity:
          Name:
            NameFull: Motley ST
      – PersonEntity:
          Name:
            NameFull: Goldschmidt RM
      – PersonEntity:
          Name:
            NameFull: Shaw KJ
      – PersonEntity:
          Name:
            NameFull: Jones TK
      – PersonEntity:
          Name:
            NameFull: Grice CA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 05
              Text: 2007 May 15
              Type: published
              Y: 2007
          Identifiers:
            – Type: issn-print
              Value: 0960-894X
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Bioorganic & medicinal chemistry letters
              Type: main
ResultId 1